Gareth Peter Gregory

31PUBLICATIONS
123CO-AUTHORS
Haematological tumoursPredictive and prognostic markersGene and molecular therapyAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 02, 2026
Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma.

|Jul 17, 2026
End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

|May 16, 2026
Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice.

|Aug 21, 2025
Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse.

Mark Waltham, Jonathan Wong, Galina Polekhina

|Jun 27, 2025
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Jack O'Shaughnessy, Arina Martynchyk, Sze Ting Lee

|Mar 07, 2025
Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis

Pageof 6

Frequent Collaborators

8 joint publications

Stephen S Opat

8 joint publications

Eliza A Hawkes

6 joint publications

Nada Hamad

5 joint publications

Jake Shortt